Prospective i-FactorTM Analysis Fusion Rate and Quality of Life
Prospective Analysis of the i-FactorTM Bone Graft on the Fusion Rate and Quality of Life of Patients With Adult Spine Deformity
1 other identifier
interventional
128
1 country
1
Brief Summary
Adult spinal deformity surgery is a complex procedure that involves many risks and complications. Bone grafts and bone substitutes are essential to achieve fusion and manage stability in spinal surgery. Autologous bone has been considered the "gold-standard" for obtaining a spinal fusion. However, the source from which to obtain it is limited. Furthermore, the problems of bone quality in patients with osteoporosis and the morbidity have forced the orthopedic community to seek other options. I-Factor ™ Bone Graft (Cerapedics, Inc., Westminster, CO) is a compound formed by peptide P-15 bound to an anorganic bone mineral of bovine origin that is composed of porous and smooth hydroxyapatite (ABM) particles. In the literature there are no articles which identify bone formation with the i-Factor ™ graft in more than 4 instrumented levels, therefore the development of this study will allow assessing the fusion rate and quality of life of patients, which could lead to an improvement in the management and decision-making of surgical procedures, as well as better control of healthcare spending
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2020
CompletedFirst Posted
Study publicly available on registry
October 30, 2020
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedFebruary 9, 2021
February 1, 2021
3 years
October 26, 2020
February 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Fusion rate
The success of the fusion at 12 and 24 months will be determined by a specialized radiologist by the evidence in the CT scan of trabecular bone bridges between the inter-transverse areas of the vertebral bodies and the absence of radiolucency adjacent to the implants.
2 years
Minimal Clinically Important Difference (MCID)
Minimal clinically important difference is defined a smallest clinical change that is important to the patient.
2 years
Short Form Health Survey-12 General Quality of life questionnaire
The questions that follow ask what you think about your health. Your answers will allow you to know how you are and to what extent you are able to do your usual activities. Patients improve when the puntuation is more than 50.
2 years
Owestry disability index
Disability index questionnaire Maximun value=100 Minimun value=0 Patients improve when this index is arround 0
2 years
VISUAL ANALOGUE SCALE
Is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. Maximun value=10 Minimun value=0 Patients improve when this index is arround 0
2 years
Scoliosis Research Society (SRS-22)
Scoliosis reseach society questionnaire 22 questions 5 options Dimensions Pain Function Selfimage Mental Health Satrisfaction Puntuation for item and test: 1(worse) - 5(better)
2 years
Study Arms (2)
Control
NO INTERVENTIONControl group: autologous bone + bench bone
i-Factor
EXPERIMENTALI-Factor group: autologous bone + bench bone + i-Factor™ bone graft
Interventions
In the i-Factor ™ group it will be placed longitudinally in the intertransverse area. Likewise, in both groups, only autologous and bench bone will be placed in the intersomatic cages. The vertebrae where the i-Factor ™ is placed will be noted on the data collection sheet.
Eligibility Criteria
You may qualify if:
- Patients of legal age.
- Patients diagnosed with adult deformity, whether due to scoliosis, imbalance, thoracolumbar curves, etc. In which the minimum number of levels to be instrumented is 5, that is, 4 intervertebral discs.
- Patients who provide their informed consent in writing. (In the event that the patient's circumstances do not allow him to grant consent, this may be provided by the legal representative).
- Present radiological tests, computed tomography and / or magnetic resonance imaging prior to surgery.
- The implants used in the surgery are Cobalt Chrome bars and Titanium screws and interbody cages.
You may not qualify if:
- Patients who are expected to be unavailable for follow-up.
- Patients with mental disabilities that make it difficult for them to fill in the questionnaires.
- Patients who have had other types of implants placed, other than Cobalt Chrome bars and Titanium screws and interbody cages.
- Patients who are going to have cemented and / or expansive screws, Peek boxes or another type of material other than Titanium.
- Underlying neurological or neuromuscular disease.
- Underlying inflammatory or tumor disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CAULE
León, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jefe de Servicio
Study Record Dates
First Submitted
October 26, 2020
First Posted
October 30, 2020
Study Start
March 1, 2021
Primary Completion
March 1, 2024
Study Completion (Estimated)
March 1, 2027
Last Updated
February 9, 2021
Record last verified: 2021-02